Welcome to InterK

InterK Peptide Therapeutics is a preclinical biotechnology company developing immune-boosting synthetic peptides to treat cancer, UV-induced skin damage, and to act as an alternative to opioid analgesics.



Contact Us
Email mail@interk.com.au

Preclinical development of peptide based therapeutic candidates in Sydney Australia

Share this page